Liberty Wealth Management LLC Black Diamond Therapeutics, Inc. Transaction History

Liberty Wealth Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$5.18 - $8.48 $2,590 - $4,240	-500 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$8.46 - $12.42 $846 - $1,242	-100 Reduced 16.67%	500 $4,000
Q2 2021 Aug 13, 2021	SELL	$12.19 - $28.17 $66,984 - $154,794	-5,495 Reduced 90.16%	600 $6,000
Q2 2021 Aug 13, 2021	BUY	$12.19 - $28.17 $68,203 - $157,611	5,595 Added 1119.0%	6,095 $600,000
Q4 2020 Feb 09, 2021	BUY	$29.47 - $35.0 $14,735 - $17,500	500 New	500 $12,000

47.6M

2.9K

69.4K

Ticker BDTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,339,500
Market Cap $78.5M
Description
Black Diamond Therapeutics, Inc., a biotechnology company, discover, develops, and commercializes medicines for patient with genetically defined tumors. It develops BDTX-189, an irreversible small molecule inhibitor that is designed to targets oncogenic proteins defined by the non-canonical epidermal growth factor receptor (EGFR) and human epide...

Get notified when there are updates to the investment portfolio of Liberty Wealth Management LLC, based on Form 13F filings with the SEC.

Stay updated on Liberty Wealth Management LLC with notifications on news.